GNH USA

Europe — EMA

Lenalidomid Zentiva

GNH USA supplies Lenalidomid Zentiva (Lenalidomide), a immunomodulatory imide drug for multiple myeloma, myelodysplastic syndromes with del(5q) and mantle

Lenalidomide

Request sourcing

1
Pack/s

What is Lenalidomide?

Lenalidomide, the active ingredient in Lenalidomid Zentiva, is a immunomodulatory imide drug (IMiD) presented as an oral tablet for oral use. It treats multiple myeloma, myelodysplastic syndromes with del(5q), and mantle cell lymphoma in appropriate patients.

GNH USA supplies Lenalidomid Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Lenalidomide used for?

Lenalidomid Zentiva is employed in hematologic malignancies and related cytogenetic disorders.

Multiple Myeloma: improves progression‑free survival and overall response in patients with relapsed or refractory disease. Myelodysplastic Syndromes with del(5q): reduces transfusion dependence and improves blood counts in patients with the cytogenetic abnormality. Mantle Cell Lymphoma: contributes to disease control in patients receiving combination therapy.

What are the side effects of Lenalidomide?

Lenalidomid Zentiva may cause a range of adverse reactions.

Common Side Effects: - Fatigue - Neutropenia - Diarrhea - Rash - Constipation - Nausea

Serious or Rare Side Effects: - Venous thromboembolism - Secondary primary malignancies - Severe neutropenia or thrombocytopenia - Hepatotoxicity - Tumor lysis syndrome - Severe skin reactions such as Stevens‑Johnson syndrome

What precautions apply to Lenalidomide?

Before initiating therapy, clinicians should consider several safety measures.

Monitor blood counts: perform regular CBC to detect cytopenias. Assess thrombotic risk: consider prophylactic anticoagulation in high‑risk patients. Avoid in pregnancy: contraindicated due to known teratogenicity. Renal impairment: evaluate renal function and adjust therapy as needed. Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture.

What does Lenalidomide interact with?

Lenalidomid Zentiva can interact with several drug classes.

Major Interactions (Avoid): - Strong CYP3A4 inducers: may markedly reduce lenalidomide exposure (e.g., rifampin). - Anticoagulants: increased risk of thrombosis when combined without prophylaxis. - Live vaccines: heightened infection risk due to immunomodulation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors: may increase drug levels (e.g., ketoconazole). - Other myelosuppressive agents: additive bone‑marrow suppression. - Hormonal contraceptives: reduced efficacy; advise alternative contraception.

Frequently asked questions

What is Lenalidomid Zentiva used for?+
Lenalidomid Zentiva is indicated for the treatment of multiple myeloma, myelodysplastic syndromes that carry the del(5q) chromosomal abnormality, and mantle cell lymphoma. In each condition it is used to improve disease control, reduce dependence on transfusions, and extend survival when prescribed by a qualified oncologist.
How does lenalidomide work?+
Lenalidomide binds to cereblon, a component of the CRL4‑CRBN E3 ubiquitin ligase complex. This binding changes the complex’s substrate profile, leading to the ubiquitination and degradation of transcription factors Ikaros and Aiolos. The resulting actions include anti‑angiogenesis, modulation of the immune response, and direct inhibition of malignant cell growth.
What is the usual dose of Lenalidomid Zentiva?+
The dosing regimen for Lenalidomid Zentiva is individualized. A prescribing physician determines the appropriate dose, schedule, and treatment duration based on the specific indication, disease stage, patient weight, renal function, and concurrent therapies. Patients should follow the exact instructions provided by their healthcare professional.
Is Lenalidomid Zentiva safe in pregnancy or breastfeeding?+
Lenalidomid Zentiva is classified as pregnancy category X because it is known to cause fetal harm. It is contraindicated in pregnancy and women of child‑bearing potential must use effective contraception. The drug is also not recommended while breastfeeding, as it may be excreted in milk and affect the infant.
How do I order Lenalidomid Zentiva from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.
How does Lenalidomid Zentiva compare with the main alternative drug or class?+
Lenalidomid Zentiva belongs to the immunomodulatory imide drug (IMiD) class, similar to thalidomide and pomalidomide. Compared with thalidomide, lenalidomide generally offers a more favorable safety profile, especially regarding peripheral neuropathy, while retaining strong anti‑myeloma activity. Pomalidomide is often reserved for patients who have progressed after lenalidomide therapy, providing an additional option in later lines of treatment.
How should Lenalidomid Zentiva be stored and handled?+
Store the tablets at ambient temperature, below 25 °C (77 °F). Keep the product in its original blister pack or container to protect it from moisture and light. Do not store in areas with high humidity or direct sunlight, and keep out of reach of children.
How is Lenalidomid Zentiva given or administered?+
Lenalidomid Zentiva is administered orally as a tablet. It may be taken with or without food, according to the prescribing physician’s guidance. Patients should swallow the tablet whole with water and follow the prescribed schedule, typically on a cyclical basis (e.g., daily for a set number of days followed by a rest period).
What are the most serious risks to watch for while taking Lenalidomid Zentiva?+
Serious risks include venous thromboembolism, severe neutropenia or thrombocytopenia, secondary primary malignancies, and significant liver toxicity. Patients should be educated to recognize signs such as unexplained swelling, shortness of breath, fever, persistent bruising, or jaundice, and report these promptly to their healthcare provider.
Who should not use Lenalidomid Zentiva?+
Lenalidomid Zentiva is contraindicated in pregnant women, individuals with known hypersensitivity to lenalidomide or any component of the formulation, and patients with severe renal impairment unless dose adjustments are made under close supervision. Caution is also advised for patients with a history of thromboembolic events or uncontrolled infections.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Lenalidomide
Route
Oral Use
Manufacturer
Zentiva, K.S.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU